Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

Go back to Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
(NASDAQ: ANIX) Delayed: 2.82 +0.07 (2.55%)
Previous Close $2.75    52 Week High
Open $2.87    52 Week Low
Day High $2.88    P/E N/A 
Day Low $2.80    EPS
Volume 139,925